Skip to main content
Premium Trial:

Request an Annual Quote

Andrew Whiteley, Alex Titomirov & David Lowe

Premium

InforMax, the Bethesda, Md., maker of the GenoMax enterprise bioinformatics system, has appointed Andrew Whiteley as its new chairman, chief executive officer and president. Whiteley, who will assume his duties on April 1, comes to InforMax from Amersham Biosciences, where he most recently served as vice president of bioinformatics. Whiteley also held positions as vice president of Amersham’s sequencing business, and site director of Amersham International PLC’s Cleveland facility. Whiteley holds bachelor’s degrees in chemistry and biochemistry from the UK’s Nottingham University.

This announcement follows a five-month search to replace InforMax founder and CEO Alex Titomirov, who first announced last October he would be stepping down to pursue other interests. While Titomirov stayed on during this transition, he has now resigned from the InforMax board.

 

Amplification startup NuGen Technologies of San Carlos, Calif., has appointed David Lowe to its advisory board. Lowe, who is currently the recipient of a Ewing Marion Kauffman fellowship in venture capital and entrepreneurship, previously held R&D positions at Genentech for 16 years, including a term as director of cardiovascular research. Lowe is a co-inventor of a drug currently in clinical trials, and developed a quantitative real-time PCR method that is now widely used. NuGen, which recently raised $10.8 million in a Series B round of financing, is marketing its Single Primer Isothermal Amplification (SPIA) technology.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.